Imvax

Personalized immunotherapies targeting solid tumors, stimulating innate and adaptive immunity

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2015 groups50 employees language imvax.com

Registered entities

Innovation

3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 77 times.

YearFilings
20181
20191
20202
20213
20222
20231
20251
20261

Social engagement

Social engagement: 3.8K social following, 2 posts in the last 12 months — above the industry median.

Investor mix

6 investors on record; lead investors include Hp Wild Holding.

Investor typeCountShare
Venture capital233%
Private equity233%
Angel & family office117%
Other / undisclosed117%
Coming soon